20n
20n turns biological data into DNA designs that enable microbes to make valuable chemicals. The company combines machine learning, data mining, AI planning, program synthesis, distributed systems and natural language processing to predict and design DNA sequences for microbial biosynthesis. Their platform integrates with DNA sequencing and synthesis workflows and is used by industrial biotech and health-focused firms to develop biologically produced fuels, materials, therapeutics, and specialty chemicals. 20n pairs computational teams with bioengineers to test designs in microbes and scale bioproduction pathways. The company focuses on computational synthetic biology for B2B customers in industrial and health biotech markets.
20n
20n turns biological data into DNA designs that enable microbes to make valuable chemicals. The company combines machine learning, data mining, AI planning, program synthesis, distributed systems and natural language processing to predict and design DNA sequences for microbial biosynthesis. Their platform integrates with DNA sequencing and synthesis workflows and is used by industrial biotech and health-focused firms to develop biologically produced fuels, materials, therapeutics, and specialty chemicals. 20n pairs computational teams with bioengineers to test designs in microbes and scale bioproduction pathways. The company focuses on computational synthetic biology for B2B customers in industrial and health biotech markets.